Literature DB >> 15695689

Sequence variation in the porB gene from B:P1.4 meningococci causing New Zealand's epidemic.

Kristin H Dyet1, Diana R Martin.   

Abstract

Since mid-1991, New Zealand has experienced an epidemic of meningococcal disease. The epidemic has been caused by serogroup B meningococci expressing PorA type P1.7-2,4, belonging to the ST-41/ST-44 complex, lineage III. Most B:P1.7-2,4 meningococci express type 4 PorB (87.0%), although case isolates with porB other than type 4 have been identified throughout the duration of the epidemic. To assess the genetic relatedness of case isolates with an alternative porB gene, multilocus restriction typing validated against multilocus sequence typing was used. This determined that B:P1.7-2,4 meningococci with a porB gene that was other than type 4 had the same clonal origin. It was concluded that strains with alternative porB genes had diverged from the original type 4 porB. Variation in porB was also shown to be associated with the uptake of DNA encoding one or two of the PorB variable regions leading to mosaic porB. Point mutation rather than horizontal transfer and recombination was implicated as the mechanism of sequence variation in some strains. This work will serve as a reference point to determine if the administration of a strain-specific vaccine increases the level of porB divergence and variation already observed in New Zealand case isolates. It also complements the study undertaken of PorA stability which showed that variation in P1.7-2,4 PorA was almost exclusively due to deletions in the P1.4 epitope of the epidemic strain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15695689      PMCID: PMC548081          DOI: 10.1128/JCM.43.2.838-842.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Genetic and immunologic characterization of a novel serotype 4, 15 strain of Neisseria meningitidis.

Authors:  M C Bash; F Lynn; N F Concepcion; J W Tappero; G M Carlone; C E Frasch
Journal:  FEMS Immunol Med Microbiol       Date:  2000-11

2.  Evaluation of porB PCR-amplicon restriction endonuclease analysis as a method to determine porB variable-region sequences in nonserotypeable meningococci.

Authors:  Kristin H Dyet; Robin S Simmonds; Diana R Martin
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

3.  Multilocus restriction typing method to predict the sequence type of meningococci.

Authors:  Kristin H Dyet; Robin S Simmonds; Diana R Martin
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

4.  Topology of outer membrane porins in pathogenic Neisseria spp.

Authors:  P van der Ley; J E Heckels; M Virji; P Hoogerhout; J T Poolman
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

Review 5.  Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes.

Authors:  C E Frasch; W D Zollinger; J T Poolman
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug

6.  Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ELISA.

Authors:  H Abdillahi; J T Poolman
Journal:  Microb Pathog       Date:  1988-01       Impact factor: 3.738

7.  Stability of PorA during a meningococcal disease epidemic.

Authors:  A F Devoy; K H Dyet; D R Martin
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

8.  Identification of variable region differences in Neisseria meningitidis class 3 protein sequences among five group B serotypes.

Authors:  G A Zapata; W F Vann; Y Rubinstein; C E Frasch
Journal:  Mol Microbiol       Date:  1992-12       Impact factor: 3.501

9.  Molecular analysis of the serotyping antigens of Neisseria meningitidis.

Authors:  I M Feavers; J Suker; A J McKenna; A B Heath; M C Maiden
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

10.  Multilocus restriction typing: a tool for Neisseria meningitidis strain discrimination.

Authors:  Désirée E Bennett; Mary T Cafferkey
Journal:  J Med Microbiol       Date:  2003-09       Impact factor: 2.472

View more
  6 in total

1.  Clonal analysis of the serogroup B meningococci causing New Zealand's epidemic.

Authors:  K H Dyet; D R Martin
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

2.  Functional and specific antibody responses in adult volunteers in new zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines.

Authors:  E Wedege; K Bolstad; A Aase; T K Herstad; L McCallum; E Rosenqvist; P Oster; D Martin
Journal:  Clin Vaccine Immunol       Date:  2007-05-09

3.  Evidence for capsule switching between carried and disease-causing Neisseria meningitidis strains.

Authors:  Amanda J Beddek; Ming-Shi Li; J Simon Kroll; T William Jordan; Diana R Martin
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

4.  Sequencing of the porB gene: a step toward a true characterization of Neisseria meningitidis.

Authors:  R Abad; B Alcalá; C Salcedo; R Enríquez; M J Uría; P Diez; J A Vázquez
Journal:  Clin Vaccine Immunol       Date:  2006-10

Review 5.  Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration.

Authors:  Janette M Harro; Brian M Peters; Graeme A O'May; Nathan Archer; Patrick Kerns; Ranjani Prabhakara; Mark E Shirtliff
Journal:  FEMS Immunol Med Microbiol       Date:  2010-05-29

6.  LOS oligosaccharide modification enhances dendritic cell responses to meningococcal native outer membrane vesicles expressing a non-toxic lipid A.

Authors:  Hannah E Jones; Alastair Copland; Hendrik Jan Hamstra; Jonathan Cohen; Jeremy Brown; Nigel Klein; Peter van der Ley; Garth Dixon
Journal:  Cell Microbiol       Date:  2013-11-06       Impact factor: 3.715

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.